Myriad Genetics's total assets for Q2 2026 were $638.90M, a decrease of -5.17% from the previous quarter. DE:MYD total liabilities were $335.00M for the fiscal quarter, a -0.39% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.